Adity Chopra
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 14, 2024
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.
Journal: EBioMedicine
Published: January 31, 2024
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults.
Journal: BMC infectious diseases
Published: October 10, 2023
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients.
Journal: EBioMedicine
Published: May 01, 2023
Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type.
Journal: Scandinavian journal of gastroenterology
Published: February 15, 2023
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants.
Journal: NPJ vaccines
Published: January 25, 2023
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study.
Journal: The Lancet. Rheumatology
Published: November 23, 2022
Immune responses to SARS-CoV-2 vaccines in celiac disease.
Journal: Scandinavian journal of gastroenterology
Published: September 01, 2022
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity.
Journal: Frontiers in immunology
Published: June 08, 2022
Last Updated: 09/26/2026